Francesco Novelli

Prof. Francesco Novelli

Department of Molecular Biotechnology and Health Sciences

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2009 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LDLuca Durelli
Luca Durelli
LAURA CONTILAURA CONTI
LAURA CONTI
MCMarinella Clerico
Marinella Clerico
DBDaniela Boselli
Daniela Boselli
GCGiulia Contessa
Giulia Contessa
Francesco NovelliFrancesco Novelli
Francesco Novelli

1 August 2016 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
MKMegan M. Kaneda
Megan M. Kaneda
Paola CappelloPaola Cappello
Paola Cappello
ANAbraham V. Nguyen
Abraham V. Nguyen
NRNatacha Ralainirina
Natacha Ralainirina
CHChanae R. Hardamon
Chanae R. Hardamon
JVJudith A. Varner
Judith A. Varner
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a low 5-year survival rate, yet new immunotherapeutic modalities may offer hope for this and other intractable cancers. Here, we report that inhibitory targeting of PI3Kγ, a key macrophage lipid kinase, stimulates antitumor immune responses, leading to improved survival and responsiveness to standard-of-care chemotherapy in animal models of PDAC. PI3Kγ selectively drives immunosuppressive transcriptional programming in macrophages that inhibits adaptive immune responses and promotes tumor cell invasion and desmoplasia in PDAC. Blockade of PI3Kγ in PDAC-bearing mice reprograms tumor-associated macrophages to stimulate CD8+ T-cell–mediated tumor suppression and to inhibit tumor cell invasion, metastasis, and desmoplasia. These data indicate the central role that macrophage PI3Kγ plays in PDAC progression and demonstrate that pharmacologic inhibition of PI3Kγ represents a new therapeutic modality for this devastating tumor type. Significance: We report here that PI3Kγ regulates macrophage transcriptional programming, leading to T-cell suppression, desmoplasia, and metastasis in pancreas adenocarcinoma. Genetic or pharmacologic inhibition of PI3Kγ restores antitumor immune responses and improves responsiveness to standard-of-care chemotherapy. PI3Kγ represents a new therapeutic immune target for pancreas cancer. Cancer Discov; 6(8); 870–85. ©2016 AACR. This article is highlighted in the In This Issue feature, p. 803

7 September 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
FRFederica Raggi
Federica Raggi
SPSimone Pelassa
Simone Pelassa
DPDaniele Pierobon
Daniele Pierobon
FPFederica Penco
Federica Penco
MGMarco Gattorno
Marco Gattorno
Maria Carla BoscoMaria Carla Bosco
Maria Carla Bosco
Macrophages (Mf) are a heterogeneous population of tissue-resident professional phagocytes and a major component of the leukocyte infiltrate at sites of inflammation, infection, and tumor growth. They can undergo diverse forms of activation in response to environmental factors, polarizing into specialized functional subsets. A common hallmark of the pathologic environment is represented by hypoxia. The impact of hypoxia on human Mf polarization has not been fully established. The objective of this study was to elucidate the effects of a hypoxic environment reflecting that occurring in vivo in diseased tissues on the ability of human Mf to polarize into classically activated (proinflammatory M1) and alternatively-activated (anti-inflammatory M2) subsets. We present data showing that hypoxia hinders Mf polarization toward the M1 phenotype by decreasing the expression of T cell costimulatory molecules and chemokine homing receptors and the production of proinflammatory, Th1-priming cytokines typical of classical activation, while promoting their acquisition of phenotypic and secretory features of alternative activation. Furthermore, we identify the triggering receptor expressed on myeloid cells (TREM)-1, a member of the Ig-like immunoregulatory receptor family, as a hypoxia-inducible gene in Mf and demonstrate that its engagement by an agonist Ab reverses the M2-polarizing effect of hypoxia imparting a M1-skewed phenotype to Mf. Finally, we provide evidence that Mf infiltrating the inflamed hypoxic joints of children affected by Oligoarticular Juvenile Idiopatic Arthritis (OJIA) express high surface levels of TREM-1 associated with predominant M1 polarization and suggest the potential of this molecule in driving M1 proinflammatory reprogramming in the hypoxic synovial environment.

16 July 2007 in Gut
Verified
Journal Article
Closed access
PDF file
LBL Valfrè di Bonzo
L Valfrè di Bonzo
IFIvana Ferrero
Ivana Ferrero
CCC Cravanzola
C Cravanzola
KMKatia Mareschi
Katia Mareschi
DRD Rustichell
D Rustichell
MPMaurizio Parola
Maurizio Parola
Background and aim: Mesenchymal stem cells from bone marrow (MSCs) may have the potential to differentiate in vitro and in vivo into hepatocytes. We investigated whether transplanted human MSCs (hMSCs) may engraft the liver of non-obese diabetic severe combined immuno-deficient (NOD/SCID) mice and differentiate into cells of hepatic lineage. Methods: Ex vivo expanded, highly purified and functionally active hMSCs from bone marrow were transplanted (caudal vein) in sublethally irradiated NOD/SCID mice that were either exposed or not to acute liver injury or submitted to a protocol of chronic injury (single or chronic intraperitoneal injection of CCl4, respectively). Chimeric livers were analysed for expression of human transcripts and antigens. Results: Liver engraftment of cells of human origin was very low in normal and acutely injured NOD/SCID mice with significantly higher numbers found in chronically injured livers. However, hepatocellular differentiation was relatively rare, limited to a low number of cells (ranging from less than 0.1% to 0.23%) as confirmed by very low or not detectable levels of human transcripts for α-fetoprotein, CK18, CK19 and albumin in either normal or injured livers. Finally, a significant number of cells of human origin exhibited a myofibroblast-like morphology. Conclusions: Transplanted hMSCs have the potential to migrate into normal and injured liver parenchyma, particularly under conditions of chronic injury, but differentiation into hepatocyte-like cells is a rare event and pro-fibrogenic potential of hMSC transplant should be not under-evaluated.

24 February 2011 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
MCMichela Capello
Michela Capello
SBSammy Ferri Borgogno
Sammy Ferri Borgogno
Paola CappelloPaola Cappello
Paola Cappello
Francesco NovelliFrancesco Novelli
Francesco Novelli

1 August 2008 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
GRGabriella Regis
Gabriella Regis
SPSara Pensa
Sara Pensa
DBDaniela Boselli
Daniela Boselli
Francesco NovelliFrancesco Novelli
Francesco Novelli
VPValeria Poli
Valeria Poli